Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock

NCT03891849 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participant enrolled. Equipment unvailable.

Conditions

Haemorrhagic Shock
Variceal Hemorrhage

Interventions

DRUG: Octreotide Injection

Sponsor

Centre Hospitalier Universitaire, Amiens